Literature DB >> 11756043

The African Green Monkey model for cutaneous and visceral leishmaniasis.

J O Olobo1, M M Gicheru, C O Anjili.   

Abstract

Non-human primates are valuable models for biomedical research because of their similarities to human anatomy, immunology and physiology. Leishmaniasis, a disease caused by protozoan parasites, has a worldwide distribution and results in high morbidity and mortality. Availability of a non-human primate model of leishmaniasis would facilitate the study of different aspects of this disease and would accelerate the development of vaccines and new drugs. In this article, some interesting features of the vervet monkey (African Green monkey) model of human cutaneous and visceral leishmaniasis are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756043     DOI: 10.1016/s1471-4922(01)02147-x

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  5 in total

1.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.

Authors:  Cynthia A Rossi; Melanie Ulrich; Sarah Norris; Douglas S Reed; Louise M Pitt; Elizabeth K Leffel
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

2.  A genetic linkage map of the vervet monkey (Chlorocebus aethiops sabaeus).

Authors:  Anna J Jasinska; Susan Service; Matthew Levinson; Erin Slaten; Oliver Lee; Eric Sobel; Lynn A Fairbanks; Julia N Bailey; Matthew J Jorgensen; Sherry E Breidenthal; Ken Dewar; Thomas J Hudson; Roberta Palmour; Nelson B Freimer; Roel A Ophoff
Journal:  Mamm Genome       Date:  2007-07-13       Impact factor: 2.957

3.  Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites.

Authors:  Angamuthu Selvapandiyan; Ranadhir Dey; Sreenivas Gannavaram; Ines Lakhal-Naouar; Robert Duncan; Poonam Salotra; Hira L Nakhasi
Journal:  J Trop Med       Date:  2011-09-06

Review 4.  Research Relevant Conditions and Pathology in Nonhuman Primates.

Authors:  Chandra Saravanan; Thierry Flandre; Carolyn L Hodo; Anne D Lewis; Lars Mecklenburg; Annette Romeike; Oliver C Turner; Hsi-Yu Yen
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

Review 5.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.